ADIL

ADIAL PHARMACEUTICALS INC

ADIL·00688A205·US·Common Stock·Healthcare - Biotechnology-13D/G

ADIL (ADIAL PHARMACEUTICALS INC) is held by 9 institutional investors as of Q2 2026. Largest holders: JANE STREET GROUP, LLC ($82,225), CITADEL ADVISORS LLC ($75,640), UBS Group AG ($49,017). Net institutional sentiment: Mixed.

9
Holders
$269,505
Total Value
57% (7)
Consensus
4 buying - 3 selling
13F: Insider & Congress: Updated regularly
ADIL

Smart Money Verdict

View all
Loading verdict
Held by 9 funds

Who's Trading

Source dates: Price Oct 16, 2026 · Insiders Jul 16, 2026 · Activists Feb 18, 2026 · Congress none

InsiderCLCoastlands Capital LPBuy $3KJul 16, 2026
InsiderCLCoastlands Capital LPBuy $5KJul 14, 2026
InsiderCLCoastlands Capital LPBuy $5KJul 10, 2026
Checking access…

Top Holders

Checking access…
Action
New
32,119$82,2250.0%+36.33%
33
New
29,547$75,6400.0%+36.33%
33
Increased
19,147(+3432.7%)$49,0170.0%+36.73%
22
Decreased
12,393(-48.9%)$31,7250.0%+52.40%
0
Unchanged
5,879$15,0500.0%+52.40%
0
Increased
5,831(+1515.2%)$14,9270.0%+37.22%
20
Decreased
304(-72.6%)$7780.0%+52.40%
0
Unchanged
50$1280.0%+52.40%
0
Unchanged
6$150.0%+52.40%
0
Exited
0(-100.0%)$70.0%+11.79%
0
ADILADILADIAL PHARMACEUTICALS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used